Enlivex Therapeutics Ltd. (ENLV)
0.9798
+0.04
(+4.23%)
USD |
NASDAQ |
Jan 20, 14:09
Enlivex Therapeutics EPS Diluted (Quarterly): -0.0917 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.205M |
| Total Expenses (Quarterly) | 2.205M |
| Enterprise Value | 5.220M |
| Earnings Yield | -54.52% |
| Normalized Earnings Yield | -54.51 |